BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Diagnosis
45 results:

  • 1. Deep response to a combination of mtor inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with
    Oh Y; Park JH; Djunadi TA; Shah Z; Chung LI; Chae YK
    Front Endocrinol (Lausanne); 2024; 15():1304188. PubMed ID: 38356955
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Decoding the role of miRNAs in oral cancer pathogenesis: A focus on signaling pathways.
    Doghish AS; El-Husseiny AA; Khidr EG; Elrebehy MA; Elballal MS; Abdel-Reheim MA; Abdel Mageed SS; Zaki MB; Mohammed OA; Khaled R; El-Dakroury WA; Noureldin S; Moustafa YM; Mangoura SA; Gedawy EM; Abulsoud AI
    Pathol Res Pract; 2023 Dec; 252():154949. PubMed ID: 37992507
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of EGFR/PI3K/AKT/mtor pathway.
    Wang J; Shang Y; Wang Y; Li Y; Wang L; Huang S; Lyu X
    Histol Histopathol; 2024 May; 39(5):647-657. PubMed ID: 37971211
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin.
    Xin Y; Jiang Q; Liu C; Qiu J
    Aging (Albany NY); 2023 Nov; 15(21):12225-12250. PubMed ID: 37925175
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circular RNAs: characteristics, functions, mechanisms, and potential applications in thyroid cancer.
    Wu M; Yuan H; Zou W; Xu S; Liu S; Gao Q; Guo Q; Han Y; An X
    Clin Transl Oncol; 2024 Apr; 26(4):808-824. PubMed ID: 37864677
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.
    Gao F; Liu H; Meng X; Liu J; Wang J; Yu J; Liu X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Golchehre Z; Chavoshzadeh Z; He J; Zhang H; Wang X
    Br J Haematol; 2023 Sep; 202(6):1151-1164. PubMed ID: 37455019
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay.
    Hegazy M; Elkady MA; Yehia AM; Elsakka EGE; Abulsoud AI; Abdelmaksoud NM; Elshafei A; Abdelghany TM; Elkhawaga SY; Ismail A; Mokhtar MM; El-Mahdy HA; Doghish AS
    Pathol Res Pract; 2023 Jun; 246():154510. PubMed ID: 37167812
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The repertoire of mutational signatures in tobacco- and non-tobacco-induced oral cancer.
    Mishra MK; Gupta S; Shivangi ; Sharma M; Sehgal S
    Clin Transl Oncol; 2023 Dec; 25(12):3332-3344. PubMed ID: 37058208
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. In-depth proteomic signature of parathyroid carcinoma.
    Kong SH; Lee JH; Bae JM; Hong N; Kim H; Park SY; Choi YJ; Lee S; Rhee Y; Kim SW; Han D; Kim JH; Shin CS
    Eur J Endocrinol; 2023 Apr; 188(4):385-394. PubMed ID: 36995894
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The molecular landscape of breast mucoepidermoid carcinoma.
    Venetis K; Sajjadi E; Ivanova M; Andaloro S; Pessina S; Zanetti C; Ranghiero A; Citelli G; Rossi C; Lucioni M; Malapelle U; Pagni F; Barberis M; Guerini-Rocco E; Viale G; Fusco N
    Cancer Med; 2023 May; 12(9):10725-10737. PubMed ID: 36916425
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Src heterodimerically activates Lyn or Fyn to serve as targets for the diagnosis and treatment of esophageal squamous cell carcinoma.
    Zhang J; Zhao D; Zhang L; Xiao Y; Wu Q; Wang Y; Chen J; Zhan Q
    Sci China Life Sci; 2023 Jun; 66(6):1245-1263. PubMed ID: 36763244
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mtor signaling pathway.
    Hu J; Li G; Liu Z; Ma H; Yuan W; Lu Z; Zhang D; Ling H; Zhang F; Liu Y; Liu C; Qiu Y
    Mol Carcinog; 2023 May; 62(5):628-640. PubMed ID: 36727616
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
    Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cystathionine γ-lyase mediates cell proliferation, migration, and invasion of nasopharyngeal carcinoma.
    Zhang Q; Gao Y; Zhang Y; Jing M; Wang D; Wang Y; Khattak S; Qi H; Cai C; Zhang J; Ngowi EE; Khan NH; Li T; Ji A; Jiang Q; Ji X; Li Y; Wu D
    Oncogene; 2022 Dec; 41(49):5238-5252. PubMed ID: 36310322
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MYH9 is a novel cancer stem cell marker and prognostic indicator in esophageal cancer that promotes oncogenesis through the PI3K/AKT/mtor axis.
    Kai JD; Cheng LH; Li BF; Kang K; Xiong F; Fu JC; Wang S
    Cell Biol Int; 2022 Dec; 46(12):2085-2094. PubMed ID: 36030536
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mortality Risk factors and SOX2 and mtor expression in Patients with Esophageal cancer.
    Yu G; Yuexin Y; Yin L; Yiyin Z; Mei K; Liyang Z; Lei X; Fan W
    Cell Mol Biol (Noisy-le-grand); 2022 Jan; 67(4):346-357. PubMed ID: 35809269
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mtor Signaling Pathway.
    Luo X; Wang J; Lu J; Wang X; Miao Y; Li Q; Li X; Wang L
    Biomed Res Int; 2022; 2022():1874550. PubMed ID: 35757470
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetics and Epigenetics of Parathyroid Carcinoma.
    Marini F; Giusti F; Palmini G; Perigli G; Santoro R; Brandi ML
    Front Endocrinol (Lausanne); 2022; 13():834362. PubMed ID: 35282432
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. ABCA8 inhibits breast cancer cell proliferation by regulating the AMP activated protein kinase/mammalian target of rapamycin signaling pathway.
    Lv C; Yang H; Yu J; Dai X
    Environ Toxicol; 2022 Jun; 37(6):1423-1431. PubMed ID: 35191604
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone.
    Cetani F; Pardi E; Marcocci C
    Endocrinol Metab Clin North Am; 2021 Dec; 50(4):683-709. PubMed ID: 34774241
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.